SIRT2 and hepatocellular carcinoma: It acts as a tumour suppressor, as SIRT2-knockout mice develop mammary tumours or hepatocellular carcinoma (Kim et al., 2011) and loss of SIRT2 facilitates tumour formation in a model of skin squamous cell carcinoma (Serrano et al., 2013).